In June 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the Parathlete Ranjeet Bhati after his sample tested positive for the prohibited substance Dehydrochlormethyltestosterone.
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete admitted the violation and denied the intentional use of the substance. He explained that he had used the substance as prescribed medication and that he was unware of the anti-doping rules and prohibited substances.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. He failed to demonstrate that the violation was not intentional.
Furthermore the Panel considers that the Athlete had not checked this medication, failed to mention this medication on the Doping Control Form, nor made an application for a TUE. Also he did not show with corroborating evidence that he indeed had informed his doctor that was an athlete subjected to doping control.
Therefore the ADDPI decides on 9 January 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 5 June 2023.
